GMP細胞銀行服務市場:各細胞類型，各終端用戶，各地區-市場規模，佔有率，展望，機會分析，2023年～2030年

Gmp Cell Banking Services Market, By Cell Type, By End User,, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年06月14日 | 出版商:

Coherent Market Insights | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態

擴大採用無機增長戰略，例如市場主要參與者進行收購以擴大其產品組合，預計將在預測期內推動市場增長。

為了擴大產品系列，市場主要企業採用設施擴張等內部成長策略的案例增多，也將促進在預測期間內的市場成長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球GMP細胞銀行服務市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球GMP細胞銀行服務市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球GMP細胞銀行服務市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球GMP細胞銀行服務市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

Increasing adoption of inorganic growth strategies, such as acquisition by key players in the market to expand their product portfolio, is expected to drive market growth over the forecast period. For instance, in June 2021, Generate Life Sciences, a life sciences company, announced that it has acquired the Cell Care Group, an international cord blood banking group that comprises cell care in Australia. Cell Care joins Generate's Cord Blood Registry in creating a global network of newborn stem cell (umbilical cord blood and tissue) banks from which to further their collective regenerative medicine research, while also providing Canadian and Australian families with greater access to reproductive and genetic services that help grow and protect healthy families from preconception into adulthood

The increasing adoption of organic growth strategies such as facility expansion by key players in the market to expand their product portfolio is expected to drive market growth over the forecast period. For instance, on April 6, 2023, Avid Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced the completion of two expansions within the company's mammalian cell facilities. The newly expanded manufacturing capacity includes both upstream and downstream CGMP manufacturing suites and serves as a complement to Avid's existing Myford facility, providing increased capacity to address the needs of both existing and future mammalian cell business customers

Key features of the study:

This report provides in-depth analysis of the global GMP cell banking services market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global GMP cell banking services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global GMP cell banking services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell banking services market

Detailed Segmentation:

Global GMP Cell Banking Services Market, By Cell Type:
- Mammalian
- Microbial
- Insect
- Yeast
- Avian
- Stem Cell Type
- Others
Global GMP Cell Banking Services Market, By End User:
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
Global GMP Cell Banking Services Market, By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Company Profiles
- WuXi AppTec Group*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Charles River Laboratories International, Inc.,
- Eurofins Scientific
- Merck KGaA
- Lonza Group Ltd.
- SGS Ltd.
- ViruSure GmbH
- Austrianova
- Goodwin Biotechnology Inc.
- Paragon Bioservices, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market PurviewS

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Cell Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2022)

4. Global GMP Cell Banking Services Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global GMP Cell Banking Services Market, By Cell Type, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Microbial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Insect
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Avian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Stem Cell Type
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global GMP Cell Banking Services Market, By End User, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global GMP Cell Banking Services Market, By Region, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

8. Competitive Landscape

WuXi AppTec Group*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Charles River Laboratories International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SGS Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ViruSure GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Austrianova
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Goodwin Biotechnology Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Paragon Bioservices, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies